Author: treatment-diabetes

What are the Patterns of Tumor Progression? Hemoblastosis has two stages: monoclonal (benign) and polyclonal – the occurrence of subclones (malignant). However, the change of stages is carried out with an unequal frequency in different

What is Factor I Deficiency? Congenital and hereditary forms of fibrinogen deficiency are described as early as 1920. Family afibrinogenemia (absence of fibrinogen in the blood plasma) is a rare disease that is inherited in

Symptoms of Autoimmune Hemolytic Anemia with Thermal Hemolysins This form of autoimmune hemolytic anemia, as a rule, begins gradually, in more rare cases, an acute onset is possible, the same as in the agglutinin form.

What is Hemorrhagic Disease of the Newborn? During the first 4-7 days after birth, there is a decrease in the concentration of coagulation factors in the plasma. Early colostrum feeding can significantly alleviate this depression

What is Hemolytic Anemia associated with a deficiency of glucose-6-phosphate dehydrogenase (G-6-FDG)? Hemolytic anemia associated with a deficiency of glucose-6-phosphate dehydrogenase (G-6-FDG) is a hereditary hemolytic anemia associated with a deficiency of enzyme activity. In

What is Hairy Cell Leukemia? Hairy-cell leukemia is a rare variant of chronic leukemia, which is considered an independent nosological unit and is currently not considered as one of the clinical and morphological variants of

What is the Rando-Osler Disease? Rando-Osler disease is the most common hereditary hemorrhagic vasopathy with focal thinning of the walls and expansion of the microvascular lumen, with inadequate local hemostasis. This pathology is inherited by

What is Markiafavi-Micheli Disease? Markiafavi-Micheli’s disease is a rather rare form of acquired hemolytic anemia, characterized by a violation of the structure of erythrocytes, neutrophils and platelets, accompanied by signs of intravascular erythrocyte destruction. An

What is Christmas Disease? The term “hemophilia B” is understood as a hereditary hemorrhagic diathesis, characterized by a deficiency in the activity of the plasma component of thromboplastin (factor IX). For the first time, hemophilia

What is Von Willebrand Disease? The disease was first studied in 1926 by the scientist Willebrand, who on the Aland Islands described a family with a kind of autosomal dominantly inherited hemorrhagic diathesis, similar to